Skip to content

Clinical trials

Phase 1/2 Leukemia, Biphenotypic, Acute trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Phase: Phase 1/2 Country / region: Canada Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group1
Kura Oncology, Inc.1
PedAL BCU, LLC1
Syndax Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute4
Leukemia, Myeloid, Acute4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia3
Hematologic Neoplasms1
Leukemia, Erythroblastic, Acute1
Leukemia, Megakaryoblastic, Acute1
Leukemia, Monocytic, Acute1
Leukemia, Myelomonocytic, Acute1
Leukemia, Myelomonocytic, Juvenile1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.